Link to this page
Sepsis Ontology
Last uploaded:
May 14, 2024
Jump to:
| Preferred Name | Rivaroxaban | |
| Synonyms |
|
|
| ID |
http://www.semanticweb.org/zchero/ontologies/2023/11/SepsisOntology#Rivaroxaban |
|
| definition |
An orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Xa with anticoagulant activity. Upon oral administration, rivaroxaban selectively binds to both free factor Xa and factor Xa bound in the prothrombinase complex. This interferes with the conversion of prothrombin (factor II) to thrombin and eventually prevents the formation of cross-linked fibrin clots. Rivaroxaban does not affect existing thrombin levels.
|
|
| label |
Rivaroxaban
|
|
| prefixIRI |
Rivaroxaban
|
|
| prefLabel |
Rivaroxaban
|
|
| reference | ||
| Synonyms |
Rivaroxaban
5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)- 1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
RIVAROXABAN
BAY 59-7939
Xarelto
|
|
| subClassOf |
http://www.semanticweb.org/zchero/ontologies/2023/11/SepsisOntology#Direct_Factor_Xa_Inhibitor |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping